BeiGene
BGNE
#936
Rank
โ‚ฌ20.25 B
Marketcap
181,77ย โ‚ฌ
Share price
-2.08%
Change (1 day)
7.75%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

We have found no dividend yield history for this company